Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation

N/AUnknownNCT02782416

National Taiwan University Hospital800 enrolled

Overview

Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Enrollment

800

Conditions

Kidney Transplantation

Interventions

Examination of latent tuberculosisOTHER

Eligibility

Sex: ALLMin age: 20 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age between 20-65 and match one of below 2. Waiting renal transplant or status post renal transplant 3. Receiving long term dialysis Exclusion Criteria: 1. Not agree to be enrolled 2. Suspected active TB 3. HIV patients 4. Viral hepatitis 5. Using immunosuppressants within 3 months before enrollment 6. Receiving lymphokine therapy 7. Hemoglobin \< 8 g/dL 8. Serum bilirubin \> 2.5 mg/dL 9. AST or ALT \> 2 times of upper normal limit 10. Lactation or pregnancy

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

Outcomes

Primary Outcomes

percentage of active TB

Time frame: 4 years

Central Contacts

Chin-Chung Shu, MD

CONTACT

+886972653087 ccshu139@ntu.edu.tw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.